Gene: FAM135A
Official Full Name: family with sequence similarity 135 member Aprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17794 | FAM135A Knockout cell line (HeLa) | Human | FAM135A | 1:3~1:6 | Negative | Online Inquiry |
KO17795 | FAM135A Knockout cell line (HCT 116) | Human | FAM135A | 1:2~1:4 | Negative | Online Inquiry |
KO17796 | FAM135A Knockout cell line (HEK293) | Human | FAM135A | 1:3~1:6 | Negative | Online Inquiry |
KO17797 | FAM135A Knockout cell line (A549) | Human | FAM135A | 1:3~1:4 | Negative | Online Inquiry |
FAM135A Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to eliminate the expression of the FAM135A gene, a critical component often associated with various cellular processes, including cell proliferation, apoptosis, and response to stress. By employing CRISPR/Cas9 technology for precise gene editing, these knockout cell lines allow researchers to analyze the consequences of FAM135A loss on cellular behavior and pathways, thus providing a powerful tool for dissecting gene function.
The key function of FAM135A Gene Knockout Cell Lines lies in their ability to facilitate targeted studies of the FAM135A protein’s role in cancer biology, immune response, and neurodegenerative diseases. Researchers can explore how the absence of this gene alters key signaling pathways, affects gene expression patterns, and influences cellular interactions, leading to a deeper understanding of disease mechanisms and potential therapeutic targets.
Scientifically, these cell lines are invaluable for both research and clinical settings, serving as instrumental models for drug testing, gene function analysis, and biomarker discovery. Their use can accelerate the understanding of the molecular underpinnings of diseases where FAM135A is implicated, significantly advancing personalized medicine approaches and enabling the design of more effective treatments.
Compared to alternative methods like RNA interference or pharmacological inhibition, FAM135A Gene Knockout Cell Lines offer unparalleled specificity and durability, providing a stable genetic alteration that does not diminish over time. This allows for long-term studies and robust experimental replicability, thus increasing the reliability of research outcomes.
The value of these cell lines extends beyond just their scientific utility; they represent a significant advancement in genetic tools available to researchers and clinicians. By facilitating innovative research possibilities, FAM135A Gene Knockout Cell Lines empower scientists to explore cutting-edge hypotheses and therapeutic strategies.
Our company specializes in advanced genetic engineering technologies, fostering a commitment to delivering high-quality biological products that enhance research capabilities and drive scientific discovery. We are dedicated to supporting the scientific community with rigorous, ethically produced cell lines that stand at the forefront of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.